Allozymes

📍 Singapore, Singapore🗓 Founded 2020👥 32 employees💰 Last funded Sep 2023
Biotechnology Research🌐 allozymes.com
Website LinkedIn
Allozymes is a fast-growing biotechnology company that applies its proprietary ultra-high-throughput platform technology to rapidly develop novel enzymes and unlock the bioeconomy across sectors. Leveraging this ultra-high screening power, Allozymes aims to build the largest enzyme data library in the world to address the current and future needs of building robust biosolutions.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Switzerland
1
United Kingdom
1
Frequently asked questions
Who invested in Allozymes?
Allozymes has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Allozymes last raise funding?
The most recent investment in Allozymes recorded on gritt.io was in September 2023.
When was Allozymes founded?
Allozymes was founded in 2020.
What industry is Allozymes in?
Allozymes operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Allozymes based?
Allozymes is headquartered in Singapore, Singapore.